Xconomy: Robotics and A.I.

Boston
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More
National
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More

1.
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing | San Francisco
2.
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear | Boston
3.
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System | New York
4.
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies | San Francisco
5.
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs | Texas
6.
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More | National

Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
Frank Vinluan | National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More
Sarah de Crescenzo | National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
Frank Vinluan | National
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
Jeff Bauter Engel | Wisconsin
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
Gareth Macdonald | National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
Frank Vinluan | National
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices
Jeff Bauter Engel | Boston
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
Bernadette Tansey | San Francisco
High-Flying Ginkgo Nets Another $290M to Program Cells Like Computers
Frank Vinluan | Boston

Read More Posts ›

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Biopharma and Tech Innovators Summer 2020
The cutting-edge companies behind the innovations disrupting biopharma and revolutionizing the healthcare landscape

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

From Our Editors · Podcast
Xcelerating Life Sciences Boston: The Highlights Podcast
Learn what's fueling Boston's biotech and digital health investment and partnership opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!